1/28
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
Cell cycle checkpoints
Regulatory points in the cell cycle that control progression
Tumor suppressor genes
Genes that inhibit cell growth and proliferation
Knudson's two hit hypothesis
Both alleles of a tumor suppressor gene must be mutated for loss of function
Genetic mechanisms for Tumor Suppressor Gene inactivation
Mutations in the gene itself
Epigenetic mechanisms for Tumor Suppressor Gene inactivation
Changes in gene expression without altering the DNA sequence
p53
Tumor suppressor gene that regulates cell cycle progression, DNA repair, cellular senescence, and apoptosis
Rb
Tumor suppressor gene that stops cell cycle progression from G1 to S phase
BRCA
Tumor suppressor gene involved in DNA repair and genome integrity
APC
Tumor suppressor gene that negatively regulates beta-catenin activity
NF-1
Tumor suppressor gene that inactivates the RAS proto-oncogene
MDM2
Protein that regulates the degradation of p53
p21
Protein that inhibits cyclin-dependent kinases and stops cell cycle progression
ARF
Protein that sequesters MDM2 and allows p53 to trigger cell cycle arrest
APC and WNT
Influence the development of familial adenomatous polyposis and affect beta-catenin levels and transcription for cancer development
Retinoblastoma
Tumor suppressor gene that shuts down the cell cycle at G1/S and prevents replication
RB gene
Gene that is inactivated in retinoblastoma and leads to uncontrolled cell growth
E2F
Protein that is released when RB is phosphorylated, leading to transcription and cell proliferation
Li-Fraumeni syndrome
Inherited p53 mutation that predisposes individuals to malignant tumors
TP53
Gene that encodes the protein p53, the most frequently mutated gene in human cancers
Neurofibromatosis Type I
Familial cancer syndrome caused by a mutation in the NF1 gene
BRCA1
Tumor suppressor gene associated with hereditary and sporadic breast cancer
BRCA2
Tumor suppressor gene associated with hereditary and sporadic breast cancer
TGF-beta
Growth-inhibitory signal that prevents phosphorylation of pRB and blocks cell cycle progression
Retinoblastoma gene
Gene that is mutated in retinoblastoma and leads to the development of multiple tumors
APC gene
Gene that is mutated in familial adenomatous polyposis and leads to continuous activation of beta-catenin
NF-1 gene
Gene that is mutated in neurofibromatosis type I and leads to inappropriate growth and tumor formation
Hereditary breast cancer
Breast cancer caused by mutations in the BRCA1 and BRCA2 genes
TGF-Beta
Growth-inhibitory signal that is inactivated in variety of carcinomas
Inherited Cancer Syndromes
Autosomal dominant syndromes associated with an increased risk of developing cancer